The immune recognition of gluten in coeliac disease

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

Coeliac disease, the most common intestinal disorder of western populations, is an autoimmune enteropathy caused by an abnormal immune response to dietary gluten peptides that occurs in genetically susceptible individuals carrying the HLA-DQ2 or -DQ8 haplotype. Despite the recent progresses in understanding the molecular mechanisms of mucosal lesions, it remains unknown how increased amounts of gluten peptides can enter the intestinal mucosa to initiate the inflammatory cascade. Current knowledge indicates that different gluten peptides are involved in the disease process in a different manner, some fragments being 'toxic' and others 'immunogenic'. Those defined as 'toxic' are able to induce mucosal damage either when added in culture to duodenal endoscopic biopsy or when administered in vivo, while those defined as 'immunogenic' are able to specifically stimulate HLA-DQ2- or DQ8-restricted T cell clones isolated from jejunal mucosa or peripheral blood of coeliac patients. These peptides are able to trigger two immunological pathways: one is thought to be a rapid effect on the epithelium that involves the innate immune response and the other represents the adaptive immune response involving CD4+ T cells in the lamina propria that recognize gluten epitopes processed and presented by antigen presenting cells. These findings are the subject of the present review.

Original languageEnglish
Pages (from-to)408-416
Number of pages9
JournalClinical and Experimental Immunology
Volume140
Issue number3
DOIs
Publication statusPublished - Jun 2005

Fingerprint

Glutens
Celiac Disease
Peptides
Poisons
Mucous Membrane
T-Lymphocytes
Adaptive Immunity
Antigen-Presenting Cells
Intestinal Mucosa
Innate Immunity
Abdomen
Haplotypes
Epitopes
Epithelium
Clone Cells
Biopsy
Population

Keywords

  • Adaptive immunity
  • Coeliac disease
  • Gluten
  • Innate immunity

ASJC Scopus subject areas

  • Immunology

Cite this

The immune recognition of gluten in coeliac disease. / Ciccocioppo, R.; Di Sabatino, A.; Corazza, Gino Roberto.

In: Clinical and Experimental Immunology, Vol. 140, No. 3, 06.2005, p. 408-416.

Research output: Contribution to journalArticle

@article{a880921bfcff4dc6b674e665ea8a3570,
title = "The immune recognition of gluten in coeliac disease",
abstract = "Coeliac disease, the most common intestinal disorder of western populations, is an autoimmune enteropathy caused by an abnormal immune response to dietary gluten peptides that occurs in genetically susceptible individuals carrying the HLA-DQ2 or -DQ8 haplotype. Despite the recent progresses in understanding the molecular mechanisms of mucosal lesions, it remains unknown how increased amounts of gluten peptides can enter the intestinal mucosa to initiate the inflammatory cascade. Current knowledge indicates that different gluten peptides are involved in the disease process in a different manner, some fragments being 'toxic' and others 'immunogenic'. Those defined as 'toxic' are able to induce mucosal damage either when added in culture to duodenal endoscopic biopsy or when administered in vivo, while those defined as 'immunogenic' are able to specifically stimulate HLA-DQ2- or DQ8-restricted T cell clones isolated from jejunal mucosa or peripheral blood of coeliac patients. These peptides are able to trigger two immunological pathways: one is thought to be a rapid effect on the epithelium that involves the innate immune response and the other represents the adaptive immune response involving CD4+ T cells in the lamina propria that recognize gluten epitopes processed and presented by antigen presenting cells. These findings are the subject of the present review.",
keywords = "Adaptive immunity, Coeliac disease, Gluten, Innate immunity",
author = "R. Ciccocioppo and {Di Sabatino}, A. and Corazza, {Gino Roberto}",
year = "2005",
month = "6",
doi = "10.1111/j.1365-2249.2005.02783.x",
language = "English",
volume = "140",
pages = "408--416",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The immune recognition of gluten in coeliac disease

AU - Ciccocioppo, R.

AU - Di Sabatino, A.

AU - Corazza, Gino Roberto

PY - 2005/6

Y1 - 2005/6

N2 - Coeliac disease, the most common intestinal disorder of western populations, is an autoimmune enteropathy caused by an abnormal immune response to dietary gluten peptides that occurs in genetically susceptible individuals carrying the HLA-DQ2 or -DQ8 haplotype. Despite the recent progresses in understanding the molecular mechanisms of mucosal lesions, it remains unknown how increased amounts of gluten peptides can enter the intestinal mucosa to initiate the inflammatory cascade. Current knowledge indicates that different gluten peptides are involved in the disease process in a different manner, some fragments being 'toxic' and others 'immunogenic'. Those defined as 'toxic' are able to induce mucosal damage either when added in culture to duodenal endoscopic biopsy or when administered in vivo, while those defined as 'immunogenic' are able to specifically stimulate HLA-DQ2- or DQ8-restricted T cell clones isolated from jejunal mucosa or peripheral blood of coeliac patients. These peptides are able to trigger two immunological pathways: one is thought to be a rapid effect on the epithelium that involves the innate immune response and the other represents the adaptive immune response involving CD4+ T cells in the lamina propria that recognize gluten epitopes processed and presented by antigen presenting cells. These findings are the subject of the present review.

AB - Coeliac disease, the most common intestinal disorder of western populations, is an autoimmune enteropathy caused by an abnormal immune response to dietary gluten peptides that occurs in genetically susceptible individuals carrying the HLA-DQ2 or -DQ8 haplotype. Despite the recent progresses in understanding the molecular mechanisms of mucosal lesions, it remains unknown how increased amounts of gluten peptides can enter the intestinal mucosa to initiate the inflammatory cascade. Current knowledge indicates that different gluten peptides are involved in the disease process in a different manner, some fragments being 'toxic' and others 'immunogenic'. Those defined as 'toxic' are able to induce mucosal damage either when added in culture to duodenal endoscopic biopsy or when administered in vivo, while those defined as 'immunogenic' are able to specifically stimulate HLA-DQ2- or DQ8-restricted T cell clones isolated from jejunal mucosa or peripheral blood of coeliac patients. These peptides are able to trigger two immunological pathways: one is thought to be a rapid effect on the epithelium that involves the innate immune response and the other represents the adaptive immune response involving CD4+ T cells in the lamina propria that recognize gluten epitopes processed and presented by antigen presenting cells. These findings are the subject of the present review.

KW - Adaptive immunity

KW - Coeliac disease

KW - Gluten

KW - Innate immunity

UR - http://www.scopus.com/inward/record.url?scp=20444446016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444446016&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2249.2005.02783.x

DO - 10.1111/j.1365-2249.2005.02783.x

M3 - Article

VL - 140

SP - 408

EP - 416

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

IS - 3

ER -